BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 27834582)

  • 1. Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness.
    Bizzarro V; Belvedere R; Migliaro V; Romano E; Parente L; Petrella A
    Cell Adh Migr; 2017 May; 11(3):247-260. PubMed ID: 27834582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid.
    Bizzarro V; Belvedere R; Milone MR; Pucci B; Lombardi R; Bruzzese F; Popolo A; Parente L; Budillon A; Petrella A
    Oncotarget; 2015 Sep; 6(28):25076-92. PubMed ID: 26312765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of annexin A1 expression by butyrate in human melanoma cells induces invasion by inhibiting E-cadherin expression.
    Shin J; Song IS; Pak JH; Jang SW
    Tumour Biol; 2016 Nov; 37(11):14577-14584. PubMed ID: 27612479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
    Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
    Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annexin A1 Expression Is Associated with Epithelial-Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer.
    Oshi M; Tokumaru Y; Mukhopadhyay S; Yan L; Matsuyama R; Endo I; Takabe K
    Cells; 2021 Mar; 10(3):. PubMed ID: 33804148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-196a Is Able to Restore the Aggressive Phenotype of Annexin A1 Knock-Out in Pancreatic Cancer Cells by CRISPR/Cas9 Genome Editing.
    Belvedere R; Saggese P; Pessolano E; Memoli D; Bizzarro V; Rizzo F; Parente L; Weisz A; Petrella A
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cells.
    Belvedere R; Bizzarro V; Popolo A; Dal Piaz F; Vasaturo M; Picardi P; Parente L; Petrella A
    BMC Cancer; 2014 Dec; 14():961. PubMed ID: 25510623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
    Murali AK; Norris JS
    J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane-initiated estrogen signaling in prostate cancer: A route to epithelial-to-mesenchymal transition.
    Gadkar S; Nair S; Patil S; Kalamani S; Bandivdekar A; Patel V; Chaudhari U; Sachdeva G
    Mol Carcinog; 2019 Nov; 58(11):2077-2090. PubMed ID: 31411358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX4 induces tumor invasion by targeting EMT-related pathway in prostate cancer.
    Liu Y; Zeng S; Jiang X; Lai D; Su Z
    Tumour Biol; 2017 May; 39(5):1010428317694539. PubMed ID: 28466783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
    Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
    J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometry based quantitative proteomics and integrative network analysis accentuates modulating roles of annexin-1 in mammary tumorigenesis.
    Swa HL; Shaik AA; Lim LH; Gunaratne J
    Proteomics; 2015 Jan; 15(2-3):408-18. PubMed ID: 25124533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin A1-suppressed autophagy promotes nasopharyngeal carcinoma cell invasion and metastasis by PI3K/AKT signaling activation.
    Zhu JF; Huang W; Yi HM; Xiao T; Li JY; Feng J; Yi H; Lu SS; Li XH; Lu RH; He QY; Xiao ZQ
    Cell Death Dis; 2018 Nov; 9(12):1154. PubMed ID: 30459351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic hypoxia-induced slug promotes invasive behavior of prostate cancer cells by activating expression of ephrin-B1.
    Iwasaki K; Ninomiya R; Shin T; Nomura T; Kajiwara T; Hijiya N; Moriyama M; Mimata H; Hamada F
    Cancer Sci; 2018 Oct; 109(10):3159-3170. PubMed ID: 30058095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of Mediator Complex Subunit 19 Suppresses the Growth and Invasion of Prostate Cancer Cells.
    Yu S; Wang Y; Yuan H; Zhao H; Lv W; Chen J; Wan F; Liu D; Gao Z; Wu J
    PLoS One; 2017; 12(1):e0171134. PubMed ID: 28125713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of netrin-1 by hypoxia contributes to the invasion and migration of prostate carcinoma cells by regulating YAP activity.
    Chen H; Chen Q; Luo Q
    Exp Cell Res; 2016 Dec; 349(2):302-309. PubMed ID: 27815019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrin-releasing peptide receptor (GRPr) promotes EMT, growth, and invasion in canine prostate cancer.
    Elshafae SM; Hassan BB; Supsavhad W; Dirksen WP; Camiener RY; Ding H; Tweedle MF; Rosol TJ
    Prostate; 2016 Jun; 76(9):796-809. PubMed ID: 26939805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI).
    Sun Y; Jia X; Gao Q; Liu X; Hou L
    IUBMB Life; 2017 Jan; 69(1):16-21. PubMed ID: 27862841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
    Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
    Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.